Product
Interferon beta 1a
Aliases
Avonex, interferon, Interferon beta type 1a
Name
interferon
2 clinical trials
2 indications
Indication
Multiple SclerosisIndication
Relapsing-RemittingClinical trial
An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label ExtensionStatus: Recruiting, Estimated PCD: 2029-11-05
Clinical trial
National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Beta-1a (REBIF 44mg 3 Times / Week) Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple SclerosisStatus: Completed, Estimated PCD: 2020-05-28